title: Economic evaluation of Varicella vaccination: results of a systematic review.
abstract: BACKGROUND
  The aim of the present study is to review the economic burden of varicella disease and the benefit of universal varicella vaccination in different settings pending its implementation in all Italian regions.
  
  
  METHODS
  Research was conducted using PubMed, Scopus and ISI databases. Score quality and data extraction were performed for all included studies.
  
  
  RESULTS
  Twenty-three articles met the criteria: 15 cost-effectiveness, 8 cost-benefit and one cost-utility analysis. Varicella vaccination could save the society from €637,762 (infant strategy) to 53 million annually (combined infant and adolescent strategy). The median and the mean quality scores resulted in 91.8% and 85.4% respectively; 11 studies were considered of high quality and 12 of low quality.
  
  
  CONCLUSIONS
  The studies are favorable to the introduction of universal varicella vaccination in Italy, being cost saving and having a positive impact on morbidity. The quality score of the studies varied greatly: recent analyses were of comparable quality to older studies.
authors.affiliation: Department of Public Health and Infectious Diseases; Sapienza University of Rome; Rome, Italy.
authors.forename: Brigid
authors.initials: B
authors.lastname: Unim
authors.forename: Rosella
authors.initials: R
authors.lastname: Saulle
authors.forename: Sara
authors.initials: S
authors.lastname: Boccalini
authors.forename: Cristina
authors.initials: C
authors.lastname: Taddei
authors.forename: Vega
authors.initials: V
authors.lastname: Ceccherini
authors.forename: Antonio
authors.initials: A
authors.lastname: Boccia
authors.forename: Paolo
authors.initials: P
authors.lastname: Bonanni
authors.forename: Giuseppe
authors.initials: G
authors.lastname: La Torre
mesh_terms: D002644:Chickenpox / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D019433:Chickenpox Vaccine / Q000008:administration & dosage* / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D007558:Italy / Q000453:epidemiology; D014611:Vaccination / Q000191:economics*
chemical_list: D019433:Chickenpox Vaccine
keywords: cost benefit; cost effectiveness; cost utility; economic evaluation; vaccination; varicella